Sotera Health Co

Lobbying Governance

AI Extracted Evidence Snippet Source

The Chair of the Nominating and Corporate Governance Committee ("Governance Committee"), has active oversight of the Company's ESG practices and policies. This responsibility also is shared by the full Board. Director experience includes deep expertise in ESG, including corporate and government environmental expertise. In addition, we work to ensure that ESG is a standing item on the Board's annual agenda. [...] Shareholder feedback is a valuable input and is incorporated into relevant Board and committee discussions. In 2021, we began a formal governance engagement program that consisted of outreach to institutional shareholders presenting more than 50% of shares not held by affiliates, in order to solicit feedback on ESG matters and address questions following the filing of our proxy statement. We furthered the program in 2022, to ensure a dialogue is maintained with ESG Co-Chairs and any feedback is communicated to the Executive Team and Board. Throughout the year, the ESG Committee seeks opportunities to connect with our investors to discuss current and ongoing ESG trends and hear their views about governance policies and practices. In addition, we engage in ESG discussions with proxy advisory firms, debt rating agencies, and key ESG ranking firms to identify trends and better understand the developing ESG environment. An external ESG consultant provides input into these discussions. [...] The company has not and does not contribute corporate dollars directly to support political candidates or campaigns. The company does, from time to time, allocate dollars to trade association memberships and for external educational efforts.

https://soterahealth.com/wp-content/uploads/2022/12/sotera-health-corporate-responsibility-report.pdf

The Chair of the Nominating and Corporate Governance Committee ("Governance Committee"), has active oversight of the Company's ESG practices and policies. This responsibility also is shared by the full Board. Director experience includes deep expertise in ESG, including corporate and government environmental expertise. In addition, we work to ensure that ESG is a standing item on the Board's annual agenda. [...] Shareholder feedback is a valuable input and is incorporated into relevant Board and committee discussions. In 2021, we began a formal governance engagement program that consisted of outreach to institutional shareholders presenting more than 50% of shares not held by affiliates, in order to solicit feedback on ESG matters and address questions following the filing of our proxy statement. We furthered the program in 2022, to ensure a dialogue is maintained with ESG Co-Chairs and any feedback is communicated to the Executive Team and Board. Throughout the year, the ESG Committee seeks opportunities to connect with our investors to discuss current and ongoing ESG trends and hear their views about governance policies and practices. In addition, we engage in ESG discussions with proxy advisory firms, debt rating agencies, and key ESG ranking firms to identify trends and better understand the developing ESG environment. An external ESG consultant provides input into these discussions. [...] The company has not and does not contribute corporate dollars directly to support political candidates or campaigns. The company does, from time to time, allocate dollars to trade association memberships and for external educational efforts.

https://soterahealth.com/wp-content/uploads/2022/12/sotera-health-corporate-responsibility-report.pdf